Next Article in Journal
CA-125 Levels Are Predictive of Survival in Low-Grade Serous Ovarian Cancer—A Multicenter Analysis
Previous Article in Journal
Pre-Clinical Study Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Neuroblastoma
Article

Comparison of Post-Transplantation Lymphoproliferative Disorder Risk and Prognostic Factors between Kidney and Liver Transplant Recipients

1
Department of Immunology, Transplantation and Internal Medicine, Medical University of Warsaw, 02-006 Warsaw, Poland
2
Institute of Biochemistry and Biophysics, Polish Academy of Sciences, 02-106 Warsaw, Poland
3
University Clinical Center, Medical University of Warsaw, 02-091 Warsaw, Poland
4
Department of General and Transplant Surgery, Medical University of Warsaw, 02-006 Warsaw, Poland
5
Department of General, Vascular and Transplant Surgery, Medical University of Warsaw, 02-097 Warsaw, Poland
6
1st Department of Nephrology and Transplantation with Dialysis Unit, Medical University of Białystok, 15-540 Białystok, Poland
7
Liver and Internal Medicine Unit, Medical University of Warsaw, 02-097 Warsaw, Poland
8
Department of General, Transplant and Liver Surgery, Medical University of Warsaw, 02-097 Warsaw, Poland
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Academic Editor: Alessandro Vitale
Cancers 2022, 14(8), 1953; https://doi.org/10.3390/cancers14081953
Received: 19 February 2022 / Revised: 1 April 2022 / Accepted: 6 April 2022 / Published: 13 April 2022
Organ graft type is an independent risk factor for the development of PTLD. Due to small cohort sizes caused by the rarity of the disease, most studies and trials are performed on populations of recipients of various organ graft types. Our study is a first direct comparison of the effect of different risk and prognostic factors between kidney and liver transplant recipients (KTRs and LTRs, respectively). We have demonstrated that the analysis of risk factors based on the general solid organ transplant recipient population is inconsistent with the results obtained through the analysis of single organ graft type cohorts. The risk of PTLD is lower in KTRs who are female, <45 years old at transplantation, or treated with cyclosporin. Based upon our findings, we are confident that the type of organ graft is an overriding factor in PTLDs’ development and course.
Post-transplantation lymphoproliferative disorder (PTLD) is a life-threatening complication of solid organ transplantation (SOT). Its development risk varies among organ graft recipients. In this study, retrospective data were analyzed to compare PTLD’s risk and prognostic factors between adult kidney and liver transplant recipients (KTRs and LTRs, respectively). Over 15 years, 2598 KTRs and 1378 LTRs were under observation at our center. Sixteen KTRs (0.62%) and twenty-three LTRs (1.67%) were diagnosed with PTLD. PTLD developed earlier in LTRs (p < 0.001), SOT patients > 45 years old (p = 0.002), and patients receiving tacrolimus (p < 0.001) or not receiving cyclosporin (p = 0.03) at diagnosis. Tacrolimus use, male sex, and age > 45 years old significantly affected the time of PTLD onset in KTRs (hazard ratio (HR) = 18.6, 7.9 and 5.2, respectively). Survival was longer in LTRs < 45 years old (p < 0.009). LTRs were more likely than KTRs to achieve complete remission (p = 0.039). Factors affecting PTLD development and outcome differ between KTRs and LTRs; thus, these populations should be separately evaluated in future studies. View Full-Text
Keywords: kidney transplantation; liver transplantation; post-transplant lymphoproliferative disorder; solid organ transplantation kidney transplantation; liver transplantation; post-transplant lymphoproliferative disorder; solid organ transplantation
Show Figures

Figure 1

MDPI and ACS Style

Mucha, K.; Staros, R.; Foroncewicz, B.; Ziarkiewicz-Wróblewska, B.; Kosieradzki, M.; Nazarewski, S.; Naumnik, B.; Raszeja-Wyszomirska, J.; Zieniewicz, K.; Pączek, L. Comparison of Post-Transplantation Lymphoproliferative Disorder Risk and Prognostic Factors between Kidney and Liver Transplant Recipients. Cancers 2022, 14, 1953. https://doi.org/10.3390/cancers14081953

AMA Style

Mucha K, Staros R, Foroncewicz B, Ziarkiewicz-Wróblewska B, Kosieradzki M, Nazarewski S, Naumnik B, Raszeja-Wyszomirska J, Zieniewicz K, Pączek L. Comparison of Post-Transplantation Lymphoproliferative Disorder Risk and Prognostic Factors between Kidney and Liver Transplant Recipients. Cancers. 2022; 14(8):1953. https://doi.org/10.3390/cancers14081953

Chicago/Turabian Style

Mucha, Krzysztof, Rafał Staros, Bartosz Foroncewicz, Bogna Ziarkiewicz-Wróblewska, Maciej Kosieradzki, Sławomir Nazarewski, Beata Naumnik, Joanna Raszeja-Wyszomirska, Krzysztof Zieniewicz, and Leszek Pączek. 2022. "Comparison of Post-Transplantation Lymphoproliferative Disorder Risk and Prognostic Factors between Kidney and Liver Transplant Recipients" Cancers 14, no. 8: 1953. https://doi.org/10.3390/cancers14081953

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop